a16z Podcast: Mindsets for Engineering Biology

Engineering biology requires a paradigm shift from repurposing off-the-shelf materials to designing biomaterials from first principles using chemistry, engineering, and biology. Historically, medical devices used materials like girdle fabric or mattress stuffing due to convenience, leading to suboptimal outcomes like blood clots from artificial hearts. Breakthroughs in controlled drug delivery—such as polymer-based microspheres enabling long-acting treatments for cancer, diabetes, and mental health—are paving the way for next-generation genetic medicines and regenerative therapies.

It reveals how rethinking biomaterials from first principles can unlock breakthrough therapies and transform drug development, regulation, and healthcare delivery.

1. 01Early medical devices often used non-optimized, repurposed materials (e.g., girdle fabric for artificial hearts, mattress stuffing for breast implants), creating long-term safety and efficacy issues due to regulatory inertia.
2. 02Controlled-release polymer systems enable long-term delivery of fragile biologics like proteins and RNA, transforming treatment for diseases including prostate cancer, endometriosis, and schizophrenia.
3. 03The future of medicine lies in engineering solutions from first principles—enabling gene therapies, regenerative medicine, and organoids for drug testing—shifting from treating disease to maintaining health.